Search IPOs
Subscription Status · Dec 10 – Dec 12, 2025 · ₹438–460
Nephrocare Health IPO subscribed 9.15 times — as of Dec 17, 2025
The Nephrocare Health IPO subscription has recorded healthy investor demand with an overall subscription of 9.15× as of Dec 17, 2025, indicating that investors applied for 9.15 times the number of shares on offer. All investor categories — institutional, HNI, and retail — have participated actively, making this one of the closely watched IPO openings.
As of December 17, 2025
| Category | Shares Offered | Shares Bid For | Times Subscribed |
|---|---|---|---|
|
QIB
Qualified Institutional Buyers
|
3,678,793 | 58,882,208 |
16.01×
|
|
NII
Non-Institutional Investors
|
2,886,270 | 51,571,328 |
17.87×
|
|
bNII
Bids above ₹10L
|
1,924,180 | 42,350,688 |
22.01×
|
|
sNII
Bids below ₹10L
|
962,090 | 9,220,640 |
9.58×
|
|
Retail
Retail Individual Investors
|
6,734,630 | 11,292,544 |
1.68×
|
|
Total
|
13,299,693 | 121,746,080 |
9.15×
|
Snapshot of each day's bidding activity
| Category | Offered | Bid For | Times |
|---|---|---|---|
| QIB | 3,678,793 | 58,882,208 | 16.01× |
| NII | 2,886,270 | 51,571,328 | 17.87× |
| bNII | 1,924,180 | 42,350,688 | 22.01× |
| sNII | 962,090 | 9,220,640 | 9.58× |
| Retail | 6,734,630 | 11,292,544 | 1.68× |
| Total | 13,299,693 | 121,746,080 | 9.15× |
As of December 17, 2025, the Nephrocare Health IPO has been subscribed 9.15 times overall. The IPO is fully subscribed.
The Nephrocare Health IPO subscription window was open from December 10, 2025 to December 12, 2025. Investors could apply through their demat account or ASBA facility.
The Nephrocare Health IPO has a price band of ₹438 to ₹460 per share, with a lot size of 32 shares. Minimum retail investment: ₹14,016 (lower band) or ₹14,720 (upper band).
The QIB category has been subscribed 16.01 times. QIBs were offered 3,678,793 shares. Strong QIB subscription indicates high institutional confidence.
Retail investors subscribed 1.68 times. Retail was offered 6,734,630 shares.
Overall NII: 17.87×. bNII (>₹10L): 22.01×, sNII (<₹10L): 9.58×. NII includes HNIs and corporate entities investing above ₹2 lakh.
Basis of allotment is on December 15, 2025. Check via the registrar's website — KFin Technologies Limited using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.
Nephrocare Health IPO is expected to list on December 17, 2025. Shares will list on NSE,BSE. Allotted shares are credited to your demat account 1 business day before listing.
A subscription multiple of 9.15× means investors have bid for 9.15 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares — allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.
Based on the current retail subscription of 1.68×, the estimated allotment probability for retail investors is Good. Decent chance of full allotment. Retail allotment in oversubscribed IPOs is done by computerised lottery — each valid application has an equal probability regardless of the number of lots applied for.
You can apply for Nephrocare Health IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from Dec 10 to Dec 12, 2025.
The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Nephrocare Health IPO GMP data, check the IPO Rise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price — use it only as a sentiment signal alongside official subscription data.
The Nephrocare Health IPO subscription tracks how many times each investor category has subscribed relative to their reserved quota. As of Dec 17, 2025, the overall subscription stands at 9.15× — Oversubscribed.
QIBs include domestic mutual funds, FIIs/FPIs, banks, insurance companies, and SEBI-registered venture capital funds. They are allocated up to 50% of the net offer (75% for SME IPOs). For Nephrocare Health IPO, QIB subscription is at 16.01×. High QIB subscription signals strong institutional conviction and is considered a positive indicator for post-listing performance.
NIIs are high-net-worth individuals (HNIs) and corporate bodies applying for more than ₹2 lakh. SEBI further divides this into bNII (bids above ₹10 lakh) and sNII (bids between ₹2–10 lakh), each with a separate allotment bucket. For Nephrocare Health IPO: bNII at 22.01×, sNII at 9.58×. Very high NII subscription (>50×) often signals leveraged HNI bidding, suggesting a strong listing expectation.
Retail investors apply for up to ₹2 lakh. They are reserved 35% of the net offer (in most mainboard IPOs). If oversubscribed, allotment is via computerised lottery — each applicant (regardless of lot count) has an equal probability. Nephrocare Health IPO retail subscription: 1.68×. With 1.68× retail subscription, allotment is lottery-based.
Price band: ₹438–₹460 per share. Lot size: 32 shares. Minimum retail investment at upper band: ₹14,720. Applications must be in multiples of 32 shares.
Stock exchanges (BSE/NSE) publish subscription data multiple times a day during the subscription window. The figures shown here represent the latest available snapshot. "Shares Offered" is the quota reserved for each category; "Shares Bid For" is the total demand received; "Times Subscribed" is the ratio of demand to supply.
Subscription Opens Done
Dec 10, 2025Subscription Closes Done
Dec 12, 2025Basis of Allotment Done
Dec 15, 2025Listing on NSE,BSE Done
Dec 17, 2025Decent chance of full allotment. Based on retail subscription of 1.68×.
Retail allotment in oversubscribed IPOs is done by computerised lottery — each valid application has equal odds regardless of lot size applied.
Share Subscription Card
Download a branded image to share on WhatsApp, Twitter, or Telegram
Higher subscription = lower allotment probability. Progress bars compare each category relative to the highest-subscribed category.